MODIFIED T-CELLS FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL CANCER

ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

CD8 BINDING AGENTS

COMBINATION TUMOR IMMUNOTHERAPY

USE OF PLK1 INHIBITOR AS MONOTHERAPY AND IN COMBINATION WITH CETUXIMAB IN TREATING RAS WILD-TYPE COLORECTAL CANCER

METHODS FOR TREATING CANCER

USE OF APICIDIN COMBINED WITH BEVACIZUMAB IN PREPARING DRUG FOR TREATING CERVICAL CANCER

METHODS, SYSTEMS, AND KITS FOR TREATMENT OF INFLAMMATORY DISEASES TARGETING TL1A

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

BISPECIFIC ANTIBODY TARGETING HK2 AND CD3 FOR THE TREATMENT OF PROSTATE CANCER

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis

METHODS OF TREATMENT COMPRISING IGG ANTIBODIES AND AN IDES PROTEASE

ANTIGEN-BINDING MOLECULES WITH INCREASED PENETRATION INTO AND RETENTION IN BRAIN, AND METHODS FOR USE THEREOF

Antibody Targeting BCMA, Bispecific Antibody, And Use Thereof

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTI-ALPHA-4-BETA-7 ANTIBODIES

MULTI-SPECIFIC ANTIBODIES AND METHODS OF USE

ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B

ANTIGEN BINDING MOLECULES

ANTI-UNC5C ANTIBODIES

IL13 AND IL31 BISPECIFIC POLYPEPTIDES AND USES THEREOF

METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE

ALPHAVIRUS ANTIGEN BINDING ANTIBODIES AND USES THEREOF

Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof

MONOCLONAL ANTIBODIES THAT BIND TO THE UNDERSIDE OF INFLUENZA VIRAL NEURAMINIDASE

Adenoviral-Based In Situ Delivery of Bispecific T Cell Engagers

ANTI-VTCN1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

FORMULATIONS WITH REDUCED OXIDATION

Method for Predicting and Modulating Glycation of a Protein

COMBINATION OF GARADACIMAB AND PROLIDASE FOR CANCER THERAPY

BISPECIFIC T CELL ENGAGERS

COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND METHODS FOR MAKING AND USING THE SAME

COMBINATION THERAPIES

TL1A BINDING PROTEINS AND METHODS OF USE

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

ANTI-KIT ANTIBODY FORMULATIONS AND METHODS

GLYCOENGINEERED POLYPEPTIDES TARGETING IMMUNOGLOBULIN A AND COMPLEXES COMPRISING THE SAME

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

SILENT ANTI-CD8 ANTIBODIES AND FUSION PROTEINS

PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES

ANTI-TREM-1 ANTIBODIES AND USES THEREOF

ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

KIDNEY TARGETING ANTIBODIES

USE OF ANTI-CLAUDIN-1 ANTIBODIES TO TREAT CHOLANGIOPATHIES

ANTI-IL-27 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODY AND APPLICATION THEREOF

VEGF ANTAGONISTS AND METHODS OF USE THEREOF

TREATMENT METHOD

METHODS AND COMPOSITIONS RELATING TO TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

COMBINATION OF RADIATION/CHEMOTHERAPY, PD-1 INHIBITOR AND FATTY ACID SYNTHASE INHIBITOR

METHODS OF USING ANTI-PSGL-1 ANTIBODIES IN COMBINATION WITH JAK INHIBITORS TO TREAT T-CELL MEDIATED INFLAMMATORY DISEASES OR CANCERS

PYRIMIDINE COMPOUND

CONDITIONALLY ACTIVE ANTI-EPCAM ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

TREM2 BINDS TO SPECIFICALLY STRUCTURED HEPARAN SULFATE

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

Anti-MuSK Agonistic Antibodies

ANTI-TYRP1 BI-SPECIFIC T CELL ENGAGING PROTEIN FOR TREATMENT OF TYRP1-EXPRESSING MELANOMA

TRANSFERRIN RECEPTOR BINDING PROTEINS FOR TREATING BRAIN TUMORS

BISPECIFIC AGONISTIC ANTIBODIES TO ACTIVIN A RECEPTOR LIKE TYPE 1 (ALK1)

PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

ANTI-PD-L1 MULTIPARATOPIC ANTIBODY CONSTRUCTS AND USES THEREOF

OPTIMIZED ANTIBODIES TARGETING CD3 AND USES THEREOF

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

ANTI-CONNEXIN ANTIBODY FORMULATIONS

ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)

PREDICTIVE BIOMARKER IN AVASTIN IN COLON CANCER

CASSETTES OF ANTI-COMPLEMENT COMPONENT 3 ANTIBODY, VECTORIZATION AND THERAPUTIC APPLICATION

MULTISPECIFIC MOLECULES FOR CLEARANCE OF IMMUNOGLOBULINS IN THE TREATMENT OF AUTOANTIBODY-INDUCED DISEASES

TISSUE PLASMINOGEN ACTIVATOR ANTIBODIES AND METHOD OF USE THEREOF

ANTI-CD24 ANTIBODIES AND USES THEREOF

ANTIBODIES TO CD70

ANTI-GLP-1R ANTIBODIES AND USES THEREOF

BINDING AGENTS AND USES THEREOF

PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

LONG ACTING ALPHA4BETA7 TARGETING MOLECULE COMPOSITIONS FOR THE TREATMENT GASTROINTESTINAL INFLAMMATORY DISEASE

METHODS OF TREATING TUMOR

METHODS FOR TREATING CHRONIC MYELOMONOCYTIC LEUKEMIA WITH ANTI-ILT3 ANTIBODIES

ANTI-CORTICOTROPIN-RELEASING HORMONE ANTIBODIES AND POLYCYSTIC OVARY SYNDROME

METHODS OF TREATING SARCOIDOSIS WITH A TNF-A ANTIBODY AND ASSOCIATED COMPOSITIONS AND METHODS

Testis Development Related Protein Antibodies

ANTI-TNF-ALPHA POLYPEPTIDE COMPOSITION AND USE THEREOF

METHODS FOR TREATING MULTIPLE MYELOMA WITH CAR-T CELLS AND BISPECIFIC ANTIBODIES

CYTOTOXICITY TARGETING CHIMERAS FOR CCR2-EXPRESSING CELLS

AN HDAC INHIBITOR FOR TREATING CANCER WITH A MODIFIED STK11 ACTIVITY OR EXPRESSION

METHODS OF TREATING CANCER

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

METHODS FOR PRODUCING POLYPEPTIDES BY REGULATING POLYPEPTIDE ASSOCIATION

COMBINATION TREATMENT FOR CANCER

CHIMERIC ANTIGEN RECEPTOR

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA

ANTI-PODXL ANTIBODIES FOR INHIBITING CTC CLUSTERING

BINDING MOLECULES AGAINST BCMA AND USES THEREOFPrivate view

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER

ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF

METHODS FOR TREATING PRIMARY SJOGREN'S SYNDROME USING FCRN ANTAGONISTS

ANTIBODIES SPECIFICALLY RECOGNIZING B- AND T-LYMPHOCYTE ATTENUATOR (BTLA) AND USES THEREOF

MULTISPECIFIC ANTIBODY AND USE THEREOF

ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

ANTI-NOTCH3 ANTIBODY

ANTI-ADRENOMEDULIN NON-NEUTRALIZING ANTIBODY, METHOD FOR PREPARING SAME, AND USE THEREOF

ANTI-IL-1ß ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF AND USE OF SAME

METHODS OF TREATING INFLAMMATORY DISEASES

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPOSITIONS AND SUBCUTANEOUS ADMINISTRATION

THE EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATION

SELECTIVE AND POTENT INHIBITORY ANTIBODIES OF MYOSTATIN ACTIVATION

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

HUMAN BROADLY NEUTRALIZING ANTIBODIES AGAINST BETACORONAVIRUSES

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

ANTI-GALECTIN 3 ANTIBODIES AND THEIR USE IN EPILEPSY AND RELATED DISEASES

ANTI-CEA IMMUNOCONJUGATES, AND USES THEREOF

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ANTIGEN-BINDING MOLECULE FOR PROMOTING ELIMINATION OF ANTIGENS

ANTIBODIES BINDING TO FIBROBLAST ACTIVATION PROTEIN ALPHA AND DEATH RECEPTOR 4

ANTI-BSSL ANTIBODIES FOR THE TREATMENT OF CANCER

PREDICTION OF AN INCREASE OF DPP3 IN A PATIENT WITH SEPTIC SHOCK

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO GUCY2C AND CD3 AND PHARMACEUTICAL USE THEREOF

ANTI-TUMOR ANTIBODIES

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

TREATMENT OF GRAFT VERSUS HOST DISEASES USING ANTI-CD122 ANTIBODY

ANTIBODIES THAT BIND TO HUMAN CCR8

MODIFIED ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT

TRIVALENT AND TRISPECIFIC ANTIBODY CONSTRUCTS AND METHODS OF USE THEREOF

RECOMBINANT HUMANIZED MONOCLONAL ANTIBODY TARGETING HUMAN GPRC5D AND APPLICATION THEREOF

METHODS OF TREATING ANKYLOSING SPONDYLITIS

ANTI-MYOSTATIN ANTIBODIES AND METHODS

TREATMENT OF OPHTHALMOLOGIC DISEASES

METHODS OF TREATING NEURODEGENERATIVE DISEASES

BROADLY NEUTRALIZING ANTIBODIES AGAINST RSV AND MPV PARAMYXOVIRUSES

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF THEIR USE FOR REDUCING THE RISK OF, TREATING, AND PREVENTING METASTASIS

ANTI-FUNGAL ANTIBODIES BINDING TO BETA GLUCAN

ANTIBODIES THAT BIND TO C1S AND USES THEREOF

CD73 (NT5E) TARGETING POLYPEPTIDES

MASKING POLYPEPTIDES, ACTIVATABLE NOVEL PRODRUGS AND METHODS OF USE THEREOF

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

ANTIBODY MONO-OR MULTI-SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF

ANTI-CD94 ANTIBODY AND USE THEREOF

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

ANTI-CD200R1 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN AND USE THEROF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER

COMBINATION HBV THERAPY

ANTI-C-MET ANTIBODY DRUG CONJUGATES

TUMOR MICROENVIRONMENT-ACTIVATED CYTOKINE AND USE THEREOF

BCMA-TARGETING AGENT, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR

NON-GENOTOXIC CONDITIONING REGIMEN FOR STEM CELL TRANSPLANTATION

COMBINATION THERAPY FOR TREATING CANCERS

RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

ANTI-IL1RAP ANTIBODIES AND METHODS OF USE THEREOF

PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

Multivalent Binding Molecules Activating WNT Signaling and Uses Thereof

ANTIBODIES SPECIFICALLY RECOGNIZING PROGRAMMED CELL DEATH1 LIGAND 1 AND USES THEREOF

ANTIGEN BINDING CONSTRUCTS TO CD8

CD47 BINDING AGENTS

ANTI-ROR1 ANTIBODY, BISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION

COMPOSITIONS AND METHODS FOR TARGETING ACTIVIN SIGNALING TO TREAT CANCER

PATHOGEN BINDING PROTEINS

RNA COMPOSITIONS TARGETING HIV

THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS)

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

MILK DERIVED EXOSOMES AND USES THEREOF

ANTI-MERTK ANTIBODIES AND THEIR METHODS OF USE

METHODS OF ADMINISTERING FVIII MIMETIC BISPECIFIC ANTIBODIES EVERY SECOND WEEK

ANTIBODIES, COMPOSITIONS, AND METHODS OF TREATMENT

BISPECIFIC ANTI-CD38-CD3 BINDERS

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

METHODS OF TREATING DISEASE USING ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES

METHODS FOR VACCINATION OF A SUBJECT TREATED WITH AN FCRN ANTAGONIST

Anti-B7-H3 Antibody and Methods of Use Thereof

BIOMARKERS FOR FIBROSIS TREATMENT USING ANTI-CLAUDIN-1 ANTIBODIES

METHODS FOR REDUCING DRUG-INDUCED LIVER INJURY

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USES THEREOF FOR TREATING CANCER CACHEXIA AND CANCER

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISORDERS

Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof

Programmable Bacteria for the Treatment of Cancer

HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES

DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

COMBINATION THERAPY METHODS WITH T-CELL ENGAGING MOLECULES FOR TREATMENT OF PROSTATE CANCER

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

TREATMENT OF EROSIVE HAND OSTEOARTHRITIS

THERAPEUTIC AND DIAGNOSTIC METHODS FOR MULTIPLE MYELOMA

VARIANT NUCLEIC ACID LIBRARIES FOR MAST CELLS

ANTI-TREM2 AGONIST ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF THAT CAN INCREASE LEVELS OF SOLUBLE TREM2 IN SERUM AND BRAIN TISSUE

Anti-SLAMF7 Antibodies And Therapeutics

Targeting the Interplay of Treg Cells and Hepatic Stellate Cells in Liver Fibrosis and Insulin Resistance

TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORIGINATING FROM THE ENDODERM

Fc VARIANTS WITH ALTERED BINDING TO FcRn

METHODS OF TREATING PAIN CAUSED BY A BONE FRACTURE

ANTI-ELASTIN ANTIBODIES AND METHODS OF USE

TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO

ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

ANTI-CHIKV ANTIBODIES AND USES THEREOF

VACCINE COMPRISING AN ANTIBODY OR AN FC-CONTAINING FUSION PROTEIN COMPRISING AN FC PART OF AN ANTIBODY

FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF

NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF

HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY

ANTI-ANGIOGENIC THERAPY AS TREATMENT FOR BENIGN UTERINE DISORDERS

METHODS TO PRESERVE TUMOR-STROMAL INTERACTIONS IN CULTURE AND THERAPEUTIC PREDICTIVE APPLICATIONS THEREOF

MULTI-SPECIFIC MOLECULES AND MENTOD OF USE AND MAKING THEREOF

ANTI-FENTANYL ANTIBODIES

VARIANT FC REGIONS

VARIANT FC REGIONS

FGF21 MIMETIC ANTIBODIES AND USES THEREOF

EPCAM-CD3 EPSILON BISPECIFIC ANTIBODIES

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

ANTIBODIES HAVING SPECIFICITY FOR CD38 AND USES THEREOF

NOVEL ANTAGONISTIC ANTI-TNFR2 ANTIBODIES

ANTI-CD137 ANTIGEN-BINDING MOLECULE AND UTILIZATION THEREOF

EPO RECEPTOR AGONISTS AND ANTAGONISTS

METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST

ANTI-CCR8 ANTIBODY AND USE THEREOFR

ANTI-CANINE INTERLEUKINE-31-RECEPTOR A (IL-31RA) ANTIBODIES AND THE USE THEREOF

DEGRADATION OF EGFR USING A BISPECIFIC BINDING AGENT

Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met Antibodes

SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF

Methods, Combinations, and Uses for the Treatment of Muscle Invasive Bladder Cancer

ANTI-PDL1 ANTIBODY FORMULATIONS

BINDING PROTEINS COMPRISING AN ANTI-IMMUNE CHECKPOINT ANTIBODY OR A FRAGMENT THEREOF AND SINGLE-CHAIN TNFRSF LIGAND MULTIMERS

IMMUNOGENIC ARGINASE 2 POLYPEPTIDES

ANTIBODY AGAINST BTLA AND USES THEREOF

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

CHIMERIC ANTIGEN RECEPTORS TARGETING GPRC5D

MULTI-SPECIFIC ANTIBODIES IN USES THEREOF IN AVIDITY RECEPTOR CROSSLINKING AND IMMUNE MODULATION

ANTIBODIES AGAINST ILT2 AND USE THEREOF

BISPECIFIC BINDING MOLECULE

IMPROVED ANTI-ALBUMIN NANOBODIES AND THEIR USES

ANTIBODIES THAT BIND TO IGE-DEPENDENT HISTAMINE-RELEASING FACTOR AND USES THEREOF

ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

ANTI-RESPIRATORY SYNCYTIAL VIRUS NEUTRALIZING ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES

TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

RECOMBINANT IMMUNOTOXIN COMPRISING A RIBOSOME INACTIVATING PROTEIN

METHODS OF TREATING THE EFFECTS OF CYTOKINE STORMS

USES AND METHODS FOR IL-2, IL-13, AND IL-4 CYTOKINE BIFUNCTIONAL MOLECULES

USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER

ANTIBODY VARIANT AND ISOFORM WITH LOWERED BIOLOGICAL ACTIVITY

FCRN/HSA BINDING MOLECULES AND METHODS OF USE

ANTIVENOM MONOCLONAL ANTIBODIES OF RUSSELLS VIPER AND USES THEREOF

TRICISTRONIC CONSTRUCTS FOR ANTI-GPC3 CAR

CD38 ANTIBODIES AND USES THEREOF

ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF

NANOBODY AND NANOBODY-DRUG CONJUGATE TARGETING CD73, METHOD FOR PREPARING SAME, AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

ANTI-EGFR/MET ANTIBODIES AND USES THEREOF

ANTI-CD1A ANTIBODIES

ANTIBODY OR FRAGMENT THEREOF THAT BINDS TO FCRL1

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

METHODS OF TREATING A NON-SMALL CELL LUNG CANCER USING AN ANTI-PD-1 ANTIBODY

NANOBODY TARGETING CD150 PROTEIN AND USE THEREOF

TARGETING GDF15-GFRAL PATHWAY

ANTI-PCRV AND PSL BISPECIFIC ANTIBODIES FOR TREATMENT OF BRONCHIECTASIS

ANTI-SARS-COV2 SPIKE (S) ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES FOR HBV SURFACE ANTIGEN (HBSAG) AND CD3 AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

BISPECIFIC ANTIBODY BINDING EGFR AND B7-H3

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

USE OF BACTERIA, BACTERIAL PRODUCTS, AND OTHER IMMUNOREGULATORY ENTITIES IN COMBINATION WITH ANTI-CTLA-4 AND/OR ANTI-PD-1 ANTIBODIES TO TREAT SOLID TUMOR MALIGNANCIES

PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-CD3 ANTIBODY AND A CXCR3 ANTAGONIST

Binding Proteins 1

METHODS OF TREATING CANCER USING TRISPECIFIC BINDING PROTEINS TARGETING HER2-EXPRESSING TUMORS

ANTI-CD40 ANTIBODY, ANTI-PD-L1×CD40 BISPECIFIC ANTIBODY, AND USE THEREOF

STRATEGY FOR HIGHLY SUPERIOR DR5 ACTIVATION INCLUDING IN TUMORS AND CANCERS

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS

COMPOSITIONS AND METHODS RELATED TO RECEPTOR PAIRINGS

Targeting Cells with a Combination of CXCR2 Inhibition and CD47 Blockade

Anti-TRPM4 Antibody For Treating Stroke

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO DLL3 AND CD3, AND PHARMACEUTICAL USE THEREOF

Anti-mGluR2 Biparatopic Nanobodies and Uses Thereof

METHOD OF ADMINISTRATION OF AN ANTI-IFN-ALPHA/-OMEGA ANTIBODY

SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY

BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOF

ANTI-SURVIVIN ANTIBODIES AND USES THEREOF

METHODS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

NOVEL TUMOR ANTIGEN-TARGETING ANTICANCER AGENT

ROR1/EGFR BI-SPECIFIC ANTIGEN BINDING MOLECULES

COMBINATION OF IL-12 AND OX40L FOR CANCER IMMUNOTHERAPY

CBL-B INHIBITORS AND ANTI-PD1/ANTI-PD-L1 FOR USE IN THE TREATMENT OF CANCER

CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS

MONOCLONAL ANTIBODY AGAINST TFPI AND USE THEREOF